{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:59:04Z","timestamp":1782741544418,"version":"3.54.5"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.phrs.2023.106790","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T02:02:29Z","timestamp":1683597749000},"page":"106790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Autoimmunity to neuronal nicotinic acetylcholine receptors"],"prefix":"10.1016","volume":"192","author":[{"given":"Maria","family":"Pechlivanidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elpinickie","family":"Ninou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Karagiorgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Tsantila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreetta","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaello","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Dudeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106790_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"vol. 147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol. Biochem Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"vol. 74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106790_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd2927","article-title":"Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system","volume":"vol. 8","author":"Taly","year":"2009","journal-title":"Nat. Rev. Drug Disco"},{"issue":"15","key":"10.1016\/j.phrs.2023.106790_bib4","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/j.1742-4658.2007.05935.x","article-title":"Muscle and neuronal nicotinic acetylcholine receptors","volume":"vol. 274","author":"Kalamida","year":"2007","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.phrs.2023.106790_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"vol. 27","author":"Gotti","year":"2006","journal-title":"Trends Pharm. Sci."},{"issue":"48","key":"10.1016\/j.phrs.2023.106790_bib6","doi-asserted-by":"crossref","first-page":"40207","DOI":"10.1074\/jbc.R112.407668","article-title":"The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily","volume":"vol. 287","author":"Changeux","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/mol.117.111401","article-title":"Ionotropic and metabotropic mechanisms of allosteric modulation of alpha7 nicotinic receptor intracellular calcium","volume":"vol. 93","author":"King","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2023.106790_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuropharm.2014.11.003","article-title":"Diversity of native nicotinic receptor subtypes in mammalian brain","volume":"vol. 96","author":"Zoli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.phrs.2023.106790_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","article-title":"Structural and functional diversity of native brain neuronal nicotinic receptors","volume":"vol. 78","author":"Gotti","year":"2009","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1570159X15666170912110450","article-title":"Neuronal and extraneuronal nicotinic acetylcholine receptors","volume":"vol. 16","author":"Zoli","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2004.04.006","article-title":"Nicotinic acetylcholine receptors and the regulation of neuronal signalling","volume":"vol. 25","author":"Dajas-Bailador","year":"2004","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2023.106790_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.609005","article-title":"Structure-function of neuronal nicotinic acetylcholine receptor inhibitors derived from natural toxins","volume":"vol. 14","author":"Ho","year":"2020","journal-title":"Front Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2023.106790_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nsmb.2900","article-title":"Crystal structures of free and antagonist-bound states of human alpha9 nicotinic receptor extracellular domain","volume":"vol. 21","author":"Zouridakis","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phrs.2023.106790_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108086","article-title":"Progress in nicotinic receptor structural biology","volume":"vol. 171","author":"Gharpure","year":"2020","journal-title":"Neuropharmacology"},{"issue":"34","key":"10.1016\/j.phrs.2023.106790_bib15","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1073\/pnas.1602619113","article-title":"Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound alpha2 homopentamer","volume":"vol. 113","author":"Kouvatsos","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7625","key":"10.1016\/j.phrs.2023.106790_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature19785","article-title":"X-ray structure of the human alpha4beta2 nicotinic receptor","volume":"vol. 538","author":"Morales-Perez","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.07.030","article-title":"Agonist selectivity and ion permeation in the alpha3beta4 ganglionic nicotinic receptor","volume":"vol. 104","author":"Gharpure","year":"2019","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.phrs.2023.106790_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the alpha7 nicotinic acetylcholine receptor","volume":"vol. 184","author":"Noviello","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2023.106790_bib19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.185","article-title":"Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans","volume":"vol. 154","author":"Wessler","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2023.106790_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biom9120827","article-title":"Attenuation in Nicotinic Acetylcholine Receptor alpha9 and alpha10 Subunit Double Knock-Out Mice of Experimental Autoimmune Encephalomyelitis","volume":"vol. 9","author":"Liu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2023.106790_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.581097","article-title":"The structure, function, and physiology of the fetal and adult acetylcholine receptor in muscle","volume":"vol. 13","author":"Cetin","year":"2020","journal-title":"Front Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2023.106790_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"vol. 2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"4088","key":"10.1016\/j.phrs.2023.106790_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"vol. 180","author":"Patrick","year":"1973","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"vol. 5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.phrs.2023.106790_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"vol. 12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"12\u201313","key":"10.1016\/j.phrs.2023.106790_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4045\/tidsskr.15.1259","article-title":"Myasthenia gravis - optimal treatment and accurate diagnosis","volume":"vol. 136","author":"Gilhus","year":"2016","journal-title":"Tidsskr. Nor. Laege"},{"issue":"9","key":"10.1016\/j.phrs.2023.106790_bib27","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1073\/pnas.85.9.2899","article-title":"Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit","volume":"vol. 85","author":"Tzartos","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02935610","article-title":"The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies","volume":"vol. 5","author":"Tzartos","year":"1991","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-5793(86)80220-4","article-title":"Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits","volume":"vol. 196","author":"Tzartos","year":"1986","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.phrs.2023.106790_bib30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"vol. 7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"vol. 7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15622975.2018.1555376","article-title":"Autoimmune encephalitis with psychosis: warning signs, step-by-step diagnostics and treatment","volume":"vol. 21","author":"Steiner","year":"2020","journal-title":"World J. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.phrs.2023.106790_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00406-020-01113-2","article-title":"Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations","volume":"vol. 270","author":"Endres","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"17","key":"10.1016\/j.phrs.2023.106790_bib34","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"vol. 30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"vol. 76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2023.106790_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23043","article-title":"Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications","volume":"vol. 6","author":"Noridomi","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2023.106790_bib37","doi-asserted-by":"crossref","unstructured":"M.S. Prevost et al., 2023, doi: 10.1101\/2023.01.03.522595.","DOI":"10.1101\/2023.01.03.522595"},{"issue":"14","key":"10.1016\/j.phrs.2023.106790_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.06.025","article-title":"Structural mechanisms of GABA(A) receptor autoimmune encephalitis","volume":"vol. 185","author":"Noviello","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00213-013-3126-5","article-title":"High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness","volume":"vol. 229","author":"Lewis","year":"2013","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"Pt B","key":"10.1016\/j.phrs.2023.106790_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2014.12.028","article-title":"Mood and anxiety regulation by nicotinic acetylcholine receptors: a potential pathway to modulate aggression and related behavioral states","volume":"vol. 96","author":"Picciotto","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2023.106790_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/B978-0-444-63432-0.00022-0","article-title":"Autoimmune autonomic disorders","volume":"vol. 133","author":"Mckeon","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106790_bib42","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1007\/s10072-022-06075-y","article-title":"Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature","volume":"vol. 43","author":"de Rojas Leal","year":"2022","journal-title":"Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106790_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autneu.2008.09.005","article-title":"Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy","volume":"vol. 146","author":"Vernino","year":"2009","journal-title":"Auton. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.10556","article-title":"The spectrum of autoimmune autonomic neuropathies","volume":"vol. 53","author":"Klein","year":"2003","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10286-017-0496-5","article-title":"Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy","volume":"vol. 28","author":"Muppidi","year":"2018","journal-title":"Clin. Auton. Res"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106790_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.autneu.2008.10.022","article-title":"Other autonomic neuropathies associated with ganglionic antibody","volume":"vol. 146","author":"Sandroni","year":"2009","journal-title":"Auton. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2023.106790_bib47","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"vol. 343","author":"Vernino","year":"2000","journal-title":"N. Engl. J. Med"},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"vol. 66","author":"McKeon","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2023.106790_bib49","first-page":"355","article-title":"Pure pan-dysautonomia with recovery","volume":"vol. 94","author":"Young","year":"1969","journal-title":"Trans. Am. Neurol. Assoc."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib50","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"vol. 50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2008.03.017","article-title":"\"Characterization of ganglionic acetylcholine receptor autoantibodies","volume":"vol. 197","author":"Vernino","year":"2008","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.61.1.44","article-title":"Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody","volume":"vol. 61","author":"Sandroni","year":"2004","journal-title":"Arch. Neurol."},{"issue":"21","key":"10.1016\/j.phrs.2023.106790_bib53","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"vol. 10","author":"Vernino","year":"2004","journal-title":"Clin. Cancer Res"},{"issue":"15","key":"10.1016\/j.phrs.2023.106790_bib54","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa051719","article-title":"Plasma exchange for primary autoimmune autonomic failure","volume":"vol. 353","author":"Schroeder","year":"2005","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archneurol.2007.60","article-title":"Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy","volume":"vol. 65","author":"Gibbons","year":"2008","journal-title":"Arch. Neurol."},{"issue":"22","key":"10.1016\/j.phrs.2023.106790_bib56","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1212\/01.wnl.0000263185.30294.61","article-title":"Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current","volume":"vol. 68","author":"Wang","year":"2007","journal-title":"Neurology"},{"issue":"32","key":"10.1016\/j.phrs.2023.106790_bib57","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1523\/JNEUROSCI.1485-04.2004","article-title":"Passive transfer of autoimmune autonomic neuropathy to mice","volume":"vol. 24","author":"Vernino","year":"2004","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib58","first-page":"336","article-title":"Neuronal nicotinic acetylcholine receptor alpha3 subunit protein in rat brain and sympathetic ganglion measured using a subunit-specific antibody: regional and ontogenic expression","volume":"vol. 77","author":"Yeh","year":"2001","journal-title":"J. Neurochem"},{"issue":"8","key":"10.1016\/j.phrs.2023.106790_bib59","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1523\/JNEUROSCI.0127-19.2020","article-title":"\u03b13* Nicotinic acetylcholine receptors in the habenula-interpeduncular nucleus circuit regulate nicotine intake","volume":"vol. 41","author":"Elayouby","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2023.106790_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577399","article-title":"Antibodies to the alpha3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis","volume":"vol. 349","author":"Yamakawa","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.phrs.2023.106790_bib61","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2169\/internalmedicine.6419-20","article-title":"Progressive encephalomyelitis with rigidity and myoclonus (PERM)-like symptoms associated with anti-ganglionic acetylcholine receptor antibodies","volume":"vol. 60","author":"Kitazaki","year":"2021","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118312","article-title":"Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients","volume":"vol. 10","author":"Nakane","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.trsl.2014.08.006","article-title":"Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases","volume":"vol. 165","author":"Burbelo","year":"2015","journal-title":"Transl. Res"},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib64","first-page":"e397","article-title":"Ganglionic acetylcholine receptor antibodies in postural tachycardia syndrome","volume":"vol. 11","author":"Bryarly","year":"2021","journal-title":"Neurol. Clin. Pr."},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib65","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001162","article-title":"Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy","volume":"vol. 9","author":"Karagiorgou","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.phrs.2023.106790_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2015.01.011","article-title":"Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases","volume":"vol. 270","author":"Rodriguez Cruz","year":"2015","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106790_bib67","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-3072","article-title":"How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases","volume":"vol. 11","author":"Gao","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"8","key":"10.1016\/j.phrs.2023.106790_bib68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"vol. 9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib69","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.celrep.2017.04.008","article-title":"NACHO mediates nicotinic acetylcholine receptor function throughout the brain","volume":"vol. 19","author":"Matta","year":"2017","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.phrs.2023.106790_bib70","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.neuron.2016.01.018","article-title":"Brain alpha7 nicotinic acetylcholine receptor assembly requires NACHO","volume":"vol. 89","author":"Gu","year":"2016","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.phrs.2023.106790_bib71","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/bph.13777","article-title":"Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update","volume":"vol. 175","author":"Crespi","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2023.106790_bib72","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/biot.200800179","article-title":"RIC-3 and nicotinic acetylcholine receptors: biogenesis, properties, and diversity","volume":"vol. 3","author":"Treinin","year":"2008","journal-title":"Biotechnol. J."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib73","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.18632\/oncotarget.13925","article-title":"\"Regulation of RIC-3 and of nAChR expression","volume":"vol. 8","author":"Ben-David","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.phrs.2023.106790_bib74","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2009.06.011","article-title":"\"Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction","volume":"vol. 78","author":"Govind","year":"2009","journal-title":"Biochem Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib75","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI17429","article-title":"Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease","volume":"vol. 111","author":"Lennon","year":"2003","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib76","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1152\/jn.00408.2003","article-title":"Experimental autoimmune autonomic neuropathy","volume":"vol. 90","author":"Vernino","year":"2003","journal-title":"J. Neurophysiol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106790_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2012.12.010","article-title":"Autoantibody-induced internalization of nicotinic acetylcholine receptor alpha3 subunit exogenously expressed in human embryonic kidney cells","volume":"vol. 257","author":"Kobayashi","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib78","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000035","article-title":"Transient neonatal autoimmune autonomic ganglionopathy","volume":"vol. 1","author":"Baker","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0029-1224873","article-title":"Transient neonatal myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother: case report and review of the literature","volume":"vol. 27","author":"Saint-Faust","year":"2010","journal-title":"Am. J. Perinatol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib80","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/mol.114.093377","article-title":"The novel alpha7beta2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization","volume":"vol. 86","author":"Moretti","year":"2014","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02740634","article-title":"Nicotinic acetylcholine receptors in health and disease","volume":"vol. 15","author":"Lindstrom","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2023.106790_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1358.024","article-title":"Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor","volume":"vol. 1062","author":"Gallowitsch-Puerta","year":"2005","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib83","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tips.2018.01.002","article-title":"Beyond the channel: metabotropic signaling by nicotinic receptors","volume":"vol. 39","author":"Kabbani","year":"2018","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2023.106790_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2022.100061","article-title":"Universal nature of cholinergic regulation demonstrated with nicotinic acetylcholine receptors","volume":"vol. 2","author":"Skok","year":"2022","journal-title":"BBA Adv."},{"issue":"11","key":"10.1016\/j.phrs.2023.106790_bib85","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000191566.86977.04","article-title":"Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis","volume":"vol. 65","author":"Watson","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","article-title":"Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances","volume":"vol. 13","author":"Varadkar","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2023.106790_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.schres.2009.01.023","article-title":"Increased antibodies for the alpha7 subunit of the nicotinic receptor in schizophrenia","volume":"vol. 109","author":"Chandley","year":"2009","journal-title":"Schizophr. Res"},{"issue":"12","key":"10.1016\/j.phrs.2023.106790_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208412","article-title":"Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder","volume":"vol. 13","author":"Hoffmann","year":"2018","journal-title":"PLoS One"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2023.106790_bib89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0891-0618(00)00109-5","article-title":"The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia","volume":"vol. 20","author":"Freedman","year":"2000","journal-title":"J. Chem. Neuroanat."},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.intimp.2014.09.022","article-title":"alpha7 Nicotinic acetylcholine receptor-specific antibody stimulates interleukin-6 production in human astrocytes through p38-dependent pathway","volume":"vol. 23","author":"Kalashnyk","year":"2014","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122706","article-title":"alpha7 Nicotinic acetylcholine receptor-specific antibody induces inflammation and amyloid beta42 accumulation in the mouse brain to impair memory","volume":"vol. 10","author":"Lykhmus","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-1838(92)90218-6","article-title":"Deficiency of sympathetic nervous system function in myasthenia","volume":"vol. 38","author":"Stoica","year":"1992","journal-title":"J. Auton. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-5728(99)00145-9","article-title":"Antibodies against neuronal nicotinic receptor subtypes in neurological disorders","volume":"vol. 102","author":"Balestra","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"vol. 15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2023.106790_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.autneu.2008.10.016","article-title":"Autoimmune autonomic ganglionopathy with late-onset encephalopathy","volume":"vol. 146","author":"Baker","year":"2009","journal-title":"Auton. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib96","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archneurol.2011.2372","article-title":"Autoimmune autonomic ganglionopathy with reversible cognitive impairment","volume":"vol. 69","author":"Gibbons","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib97","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.intimp.2015.04.046","article-title":"Pemphigus vulgaris antibodies target the mitochondrial nicotinic acetylcholine receptors that protect keratinocytes from apoptolysis","volume":"vol. 29","author":"Chernyavsky","year":"2015","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106790_bib98","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"vol. 45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib99","article-title":"Mitochondrial autoantibodies and the role of apoptosis in pemphigus vulgaris","volume":"vol. 11","author":"Hutchison","year":"2022","journal-title":"Antibodies (Basel)"},{"issue":"6","key":"10.1016\/j.phrs.2023.106790_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233957","article-title":"Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab","volume":"vol. 15","author":"Bhatia","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106790_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660342","article-title":"Cholinergic system and its therapeutic importance in inflammation and autoimmunity","volume":"vol. 12","author":"Halder","year":"2021","journal-title":"Front Immunol."},{"issue":"5\u20136","key":"10.1016\/j.phrs.2023.106790_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000355835","article-title":"The non-neuronal cholinergic system in health and disease","volume":"vol. 92","author":"Beckmann","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.phrs.2023.106790_bib103","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-3-642-23274-9_18","article-title":"Muscarinic receptor agonists and antagonists: effects on keratinocyte functions","volume":"no. 208","author":"Grando","year":"2012","journal-title":"Handb. Exp. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib104","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000451023","article-title":"Stimulation of the nonneuronal cholinergic system by highly diluted acetylcholine in keratinocytes","volume":"vol. 203","author":"Uberti","year":"2017","journal-title":"Cells Tissues Organs"},{"issue":"4","key":"10.1016\/j.phrs.2023.106790_bib105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ced.14124","article-title":"Role of the cutaneous extraneuronal cholinergic system in the pathogenesis of psoriasis: a case-control study","volume":"vol. 45","author":"Abu Zeid","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106790_bib106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-961816","article-title":"The non-neuronal cholinergic system of human skin","volume":"vol. 39","author":"Kurzen","year":"2007","journal-title":"Horm. Metab. Res"},{"issue":"5","key":"10.1016\/j.phrs.2023.106790_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/000155502320624069","article-title":"Palmoplantar pustulosis: an autoimmune disease precipitated by smoking","volume":"vol. 82","author":"Hagforsen","year":"2002","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106790_bib108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2133.2002.04640.x","article-title":"Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis","volume":"vol. 146","author":"Hagforsen","year":"2002","journal-title":"Br. J. Dermatol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:04Z","timestamp":1760913784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":108,"alternative-id":["S1043661823001469"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106790","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity to neuronal nicotinic acetylcholine receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106790"}}